FR051, a novel Hexosamine Biosynthetic Pathway inhibitor, induces cell death in breast and pancreatic cancer models.Francesca Ricciardiello(University of Milano-Bicocca)BOA (University of Milano-Bicocca)April 27, 2017Cited by 0SaveCiteExport RISWatch citationsRelated PapersSuppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor|Cells|2021|21